Core Viewpoint - Yongtai Bio-B (06978) has issued convertible bonds in 2023, with a framework agreement established for new bond subscriptions to repay existing bonds [1] Group 1: Bond Issuance Details - The 2023 convertible bonds were issued on February 20, 2023, and will mature on February 20, 2026 [1] - A framework agreement was signed with investor Jiaze Global Capital Limited on January 20, 2026, for the subscription of new convertible bonds worth 270 million HKD and notes worth 30 million HKD [1] - The proceeds from the subscription will be used exclusively for the full repayment of the principal amount of the 2023 convertible bonds [1] Group 2: Pricing Information - The initial conversion price for the new convertible bonds is set at 2.92 HKD per share, which is approximately 5.8% higher than the last trading price of 2.76 HKD per share on the Hong Kong Stock Exchange [1]
永泰生物-B(06978)拟向嘉泽全球资本发行2.7亿元的新可换股债券及3000万元的票据以清偿2023年可换股债券的本金额